259 related articles for article (PubMed ID: 20035982)
1. Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men.
Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Albala DM; Donatucci CF; Moul JW
Urology; 2010 Nov; 76(5):1058-62. PubMed ID: 20035982
[TBL] [Abstract][Full Text] [Related]
2. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone.
Crawford ED; Moul JW; Rove KO; Pettaway CA; Lamerato LE; Hughes A
BJU Int; 2011 Dec; 108(11):1743-9. PubMed ID: 21711431
[TBL] [Abstract][Full Text] [Related]
4. Racial Variation in the Outcome of Subsequent Prostate Biopsies in Men With an Initial Diagnosis of Atypical Small Acinar Proliferation.
Scott Libby R; Kramer JJ; Tue Nguyen HM; Feibus A; Thomas R; Silberstein JL
Clin Genitourin Cancer; 2017 Dec; 15(6):e995-e999. PubMed ID: 28566201
[TBL] [Abstract][Full Text] [Related]
5. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
Yanke BV; Carver BS; Bianco FJ; Simoneaux WJ; Venable DD; Powell IJ; Eastham JA
BJU Int; 2006 Oct; 98(4):783-7. PubMed ID: 16978273
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen concentration in young men: new estimates and review of the literature.
Sutcliffe S; Pakpahan R; Sokoll LJ; Elliott DJ; Nevin RL; Cersovsky SB; Walsh PC; Platz EA
BJU Int; 2012 Dec; 110(11):1627-35. PubMed ID: 22502603
[TBL] [Abstract][Full Text] [Related]
7. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
8. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
[TBL] [Abstract][Full Text] [Related]
9. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
11. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences.
Tang P; Du W; Xie K; Fu J; Chen H; Yang W; Moul JW
Prostate; 2012 Feb; 72(2):173-80. PubMed ID: 21538426
[TBL] [Abstract][Full Text] [Related]
13. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
[TBL] [Abstract][Full Text] [Related]
14. Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer.
Kuvibidila S; Rayford W
J Lab Clin Med; 2006 Apr; 147(4):174-81. PubMed ID: 16581345
[TBL] [Abstract][Full Text] [Related]
15. Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men.
Donin NM; Loeb S; Cooper PR; Roehl KA; Baumann NA; Catalona WJ; Helfand BT
BJU Int; 2014 Dec; 114(6b):E50-E55. PubMed ID: 24712975
[TBL] [Abstract][Full Text] [Related]
16. Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
Caire AA; Sun L; Polascik TJ; Albala DM; Moul JW
BJU Int; 2010 Oct; 106(8):1157-60. PubMed ID: 20367635
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
18. Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?
Mouraviev V; Broadwater G; Sun L; Mayes JM; Moul JW; Polascik TJ
Urology; 2008 Jun; 71(6):1020-3. PubMed ID: 18267331
[TBL] [Abstract][Full Text] [Related]
19. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.
Fowke JH; Signorello LB; Chang SS; Matthews CE; Buchowski MS; Cookson MS; Ukoli FM; Blot WJ
Cancer; 2006 Nov; 107(10):2361-7. PubMed ID: 17031814
[TBL] [Abstract][Full Text] [Related]
20. Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.
Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Albala DM; Donatucci CF; Moul JW
J Urol; 2010 Mar; 183(3):946-50. PubMed ID: 20083275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
